Analyst Maggie Nolan of William Blair maintained a Buy rating on Genpact, retaining the price target of $37.00.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Maggie Nolan has given his Buy rating due to a combination of factors that underscore Genpact’s improving growth profile and strategic positioning in AI‑enabled services. She views the company’s advanced technology solutions as a key engine of higher‑margin, annuity‑like revenue, with strong data and AI pipeline momentum expected to support sustained double‑digit expansion.
At the same time, Nolan highlights the steady evolution of Genpact’s legacy business and contract structures toward outcome‑based and transaction‑linked models that should lift profitability and scalability over time. Her conviction is reinforced by management’s clear execution roadmap, focus on client adoption of agentic solutions, and confidence in meeting medium‑term financial objectives laid out for investors.
Based on the recent corporate insider activity of 58 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of G in relation to earlier this year.